An Undersized Stent Does Not Forgive by Triantafyllou, Konstantinos et al.
31 
 
 
CASE REPORT 
 
An Undersized Stent Does Not Forgive 
 
Konstantinos Triantafyllou, MD,1 Dimitrios Oikonomou, 
MD,1 Dimitra Benia, MD,1 Antigoni Kyparissi, MD,1 
Georgios Ferentinos, MD,1 Dimitrios Stalikas, MD,1 
Konstantinos Kappos, MD1 
 
1First Department of Cardiology, Evagelismos Hospital, 
Athens, Greece; e-mail: kontriad@gmail.com 
 
Abstract 
 
Stent thrombosis is a rare complication of percutaneous 
coronary intervention (PCI) with potential devastating results. 
Stent undersizing and malapposition are major risk factors of 
stent thrombosis and have been strongly associated with early 
stent thrombosis. However, despite the continuous progress of 
interventional cardiology, there is no consensus regarding 
optimal management of this medical emergency. Herein, we 
present a case of subacute stent thrombosis that manifested as a 
severe inferior ST-elevation myocardial infarction four days 
after an initial PCI of the right coronary artery. A stepwise 
treatment approach was followed aiming initially to achieve flow 
TIMI III without stenting during primary PCI. During a revision 
procedure, stent undersizing and malapposition were identified 
as underlying mechanisms of stent thrombosis using 
intravascular imaging guidance and treated successfully with 
corrective PCI. Further evidence is needed to refine the optimal 
treatment strategy in the setting of stent thrombosis. Rhythmos 
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Introduction 
 
In the era of newer generation drug-eluted stents 
(DES) and more potent antiplatelet therapy, stent 
thrombosis remains a major concern in the field of 
interventional cardiology. Although stent thrombosis is a 
rare complication of percutaneous coronary intervention 
(PCI),1 it is associated with high rates of morbidity and 
mortality.2 Risk factors are recognized to be patient-
related, lesion-related, procedure-related, device-related 
and pharmarcotherapy-related. Cumulative evidence 
suggests that coronary stent undersizing and malapposition 
are established predictors of stent thrombosis3 and 
prominent underlying mechanisms regarding early stent 
thrombosis.4 Management of stent thrombosis is 
challenging for interventional cardiologists as scarce data 
are available regarding the optimal treatment strategies in 
the various clinical scenarios of such a life-threatening 
complication.5 
We herein report a case of subacute stent thrombosis 
occurring 4 days after the initial PCI that apparently was 
related to stent undersizing and malapposition.  
 
Case presentation 
 
A 73-year-old male presented with severe chest pain, 
diaphoresis and nausea to our emergency department 2 
hours after symptom onset. The electrocardiogram 
revealed an inferior ST-elevation myocardial infarction 
(STEMI) with complete atrioventricular block. Four days 
earlier he had undergone a scheduled coronary angiogram 
at another institution due to new-onset effort angina. A 
single vessel coronary artery disease was diagnosed, 
followed by PCI of the right coronary artery (RCA). No 
report of the procedure was available at the time of 
admission in our hospital. The patient had a past medical 
history of diabetes mellitus, arterial hypertension, chronic 
obstructive pulmonary disease and obesity. He was on dual 
antiplatelet therapy with aspirin and clopidogrel, ramipril, 
β-blocker, atorvastatin, metformin and pantoprazole. Good 
compliance with the prescribed treatment was reported. On 
admission the patient was hemodynamically unstable 
(blood pressure: 80/50 mmHg, heart rate: 35 bpm). The 
echocardiographic assessment showed a left ventricular 
ejection fraction of 40% with akinesis of inferior and 
lateral walls. His initial laboratory results revealed mildly 
elevated high-sensitivity troponin (30 pg/ml), elevated 
creatinine (2.1 mg/dl) and hyperglycemia.  
He was immediately transferred to the catheterization 
laboratory for emergency coronary angiography intending 
to perform primary PCI. The right femoral approach was 
selected due to cardiogenic shock with complete 
atrioventricular block. A temporary pacemaker lead was 
initially inserted from the right femoral vein in order to 
pace at 80 bpm and improve the hemodynamic condition. 
Coronary angiography showed no significant lesion in the 
left coronary artery (Fig. 1A), while there was an acute 
thrombotic occlusion at the first segment of the RCA, 
within the previously stented area with two stents 
extending from the proximal to mid-segment (Fig. 1B). 
Heavy thrombus burden and TIMI flow 0 were present. 
Considering the lack of information regarding the stent 
dimensions and types used in the previous PCI, a decision 
was made to perform primary PCI without stenting if at all 
possible. After crossing the RCA occlusion with a 
conventional guidewire without difficulty (Fig. 1C), 
thrombus aspiration was performed with restoration of 
TIMI II flow after two runs (Fig. 1D). To further improve 
flow, a balloon inflation with a 3x25mm balloon was 
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performed in the stented area at the mid-RCA (Fig. 1E). 
Finally, TIMI III flow was restored, despite the significant 
remaining thrombotic burden in the stented area (Fig. 1F). 
The vessel environment was judged not suitable for stent 
implantation, while the patient had already significant 
clinical improvement with resolution of ST segment 
elevation and restoration of sinus rhythm. He was 
transferred to the coronary care unit for monitoring. 
Antithrombotic treatment after PCI included aspirin, 
ticagrelor, enoxaparin for 5 days and tirofiban for 48 hours.  
 
  
Figure 1. Emergency coronary angiography and primary PCI. A. Left 
coronary artery without significant lesion, B. Dominant RCA occluded 
at the 1st segment, with a stented zone (with 2 consecutive stents) 
extending from the proximal to mid-segment (arrows show the 
beginning and the end of the stented zone). Heavy thrombus burden and 
flow TIMI 0 are noted (without retrograde filling of the distal RCA), C. 
Crossing the occlusion with a conventional guidewire, D. Thrombus 
aspiration with TIMI II flow restoration after the second run, E. Balloon 
inflation with a 3x25 balloon in the stented area at the mid-RCA (at 6 
atmospheres for 15 sec), F. Final result: TIMI III flow was restored. 
 
A new coronary angiography to image stents with 
optical coherence tomography (OCT) was scheduled in 6 
days. The patient remained symptom free and without 
complications until then. Meanwhile the previous PCI 
report and video loops became available and were 
reviewed. The procedure had been performed through a 
narrow and tortuous high take-off right radial artery, with 
great technical difficulty (Fig. 2A). Left coronary artery 
did not have any significant lesion (Fig. 2B). RCA had a 
long significant atheroma, extending from the proximal to 
the mid-segment where a severe stenosis (80%) was noted 
(Fig. 2C). The lesion was directly stented with a 3x38mm 
DES (Fig. 2D). A second 3.5x12mm DES was added 
proximally (with a minimum overlap zone) to cover 
residual atheroma at the proximal segment and a quite 
good angiographic result was obtained (Fig. 2E).  
Repeat coronary angiography with intracoronary 
imaging via optical coherence tomography (OCT) was 
performed 6 days later. The RCA was angiographically 
improved, free of visible thrombus, with TIMI III flow 
(Fig. 3). 
 
Figure 2. Initial PCI A. The procedure had been performed through a 
high take-off, narrow and tortuous right radial artery, B. Left coronary 
artery without any significant lesion, C. Right coronary artery with a 
long significant atheroma, extending from the proximal to the mid-
segment where a severe stenosis (80%) was noted, D. Direct stenting of 
the lesion with a 3x38mm DES, E. A second 3.5x12mm DES was added 
proximally (with a minimum overlap zone) to cover residual atheroma 
at the proximal segment with a good angiographic result as shown. 
 
OCT examination was chosen in order to understand 
the subacute stent thrombosis mechanism. The distal 
reference diameter at mid-RCA was measured around 3.5 
mm (Fig. 3A). The distal 3x38 mm stent was mostly well-
apposed in mid RCA (Fig. 3B), with limited areas of 
underexpansion and malapposition (within-stent mean 
diameter around 2.5mm) (Fig. 3C). At the stent overlap 
zone (at the end of the proximal RCA segment) the mean 
diameter was 2.58 mm, while the overlapping stents had 
nominal diameters of 3 mm & 3.5 mm respectively (Fig. 
3D). The proximal part of the proximal RCA stent was 
significantly undersized and malapposed: the obtained in-
stent mean diameter was around 3.3-3.5mm for a reference 
vessel diameter of ≥4.5mm (Fig. 3E, 3F).  
 
 
Figure 3. Revision coronary angiogram under OCT-guidance A. Distal 
reference diameter at mid-RCA was measured around 3.5mm, B. The 
3x38mm stent was mostly well apposed in mid RCA, C. Limited areas 
of underexpansion and malapposition (with in-stent mean diameter 
around 2.5mm), D. At the stent overlap zone the mean diameter was 
2.58mm, while the overlapping stents had nominal diameters of 3mm 
& 3.5mm, E, F. The proximal part of the proximal RCA stent was 
significantly undersized and malapposed: obtained in-stent mean 
diameter of 3.3-3.5mm for a reference vessel diameter of ≥ 4.5mm. 
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Obviously, stent undersizing and malapposition was 
the most probable mechanism for the subacute stent 
thrombosis. Before proceeding to corrective PCI, we 
verified the expansion limits of the DES previously used. 
The 3x38mm DES extending from the proximal to mid-
RCA could be expanded up to 3.85mm and the additional 
3.5x12mm DES in the proximal RCA could be expanded 
up to 4.75mm. With the aim to adapt DES expansion to the 
vessel’s reference diameters and correct undersizing and 
malapposition we proceeded to PCI. A 3.5x30mm non-
compliant balloon was dilated in the stented area distally 
and then more proximally at 18 Atm (Fig. 4A, 4B). A 
4.5x21mm non-compliant balloon was positioned to 
extend from the proximal DES entry point, through the 
DES overlap zone and into the proximal part of the more 
distal DES and was inflated at 14 Atm (Fig. 4C). 
Considering the 3x38mm stent expansion limit (3.85mm) 
this balloon was oversized, but it was mostly important to 
correct undersizing and malapposition of the proximal 
3.5x12mm DES (with an expansion limit at 4.75mm) and 
approach the reference vessel diameter which was at least 
4.5mm for the proximal RCA. A good final angiographic 
result was obtained (Fig. 4D).  
 
 
Figure 4. Revision PCI under OCT-guidance A, B. Dilation of a 
3.5x30mm non-compliant balloon in the stented area distally and then 
more proximally (18 Atm), C. Dilation of a 4.5x21mm non-compliant 
balloon from the proximal DES entry point, through the DES overlap 
zone and into the proximal part of the more distal DES (14 Atm), D. A 
satisfactory final angiographic result was obtained. 
 
A final control with OCT revealed good stent 
expansion and apposition throughout the stented mid-RCA 
(Fig. 5A, 5B), while the stent overlap zone was now well-
expanded with mean diameter around 3.5mm (Fig. 5C). No 
signs of stent structural disruption at the proximal 8-10mm 
of the 3x38mm DES were noted after the final post-
dilatation with the 4.5x21mm non-compliant balloon. This 
final post-dilatation led to improved expansion of the 
proximal RCA DES, obtaining mostly good apposition 
with mean stent diameter around 4.5mm at the previous 
area of undersizing and malapposition (Fig. 5D). At the 
initial 2mm of the proximal DES minimal malapposition 
persisted since the reference diameter there was around 
4.8mm (slightly beyond the maximum expansion limit of 
the DES) (Fig. 5E).  
 
 
Figure 5. Final control with OCT. A, B. Good stent expansion and 
apposition throughout the stented mid-RCA, C. Stent overlap zone 
well-expanded with mean diameter around 3.5 mm. No signs of stent 
structural disruption at the proximal 8-10mm of the 3x38mm DES after 
the final post-dilatation with the 4.5x21mm non-compliant balloon, D. 
Improved expansion of the proximal DES, obtaining mostly good 
apposition with mean stent diameter ~4.5mm at the previous area of 
undersizing and malapposition, E. At the initial 2mm of the proximal 
DES minimal malapposition persisted since the reference diameter in 
this segment was ~4.8mm (slightly beyond the maximum expansion 
limit of the DES). 
 
The overall result however was considered satisfactory 
and it was decided not to further overstretch the proximal 
DES with a post-dilatation with a non-compliant balloon 
of 5mm diameter. The patient was discharged without 
complications the following day. There was no adverse 
event during the initial follow-up at 6 months. 
 
Discussion 
 
We described a case of subacute thrombosis related to 
undersized and malapposed DES manifesting as an acute 
inferior STEMI (despite uninterrupted dual antiplatelet 
therapy) that was successfully treated initially by primary 
PCI with thrombus aspiration and lesion dilation to achieve 
TIMI III flow, then with intensive antithrombotic therapy 
for a few days to obtain residual thrombus dissolution and 
finally by performing a revision OCT-guided PCI to 
correct undersizing and malapposition. 
Optimal management of stent thrombosis has not been 
well defined in randomised trials due to the rarity of this 
complication and the fact that it consists a medical 
emergency.6 According to current guidelines routine 
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deferred stenting and routine thrombus aspiration should 
be avoided in the setting of STEMI.7  However, in the case 
of stent thrombosis high burden of thrombus, lack of 
information regarding the size and the type of the 
thrombosed stent and unawareness of the underlying 
mechanism in the acute setting, as in our case, could be 
preventing factors for deployment of an additional stent. 
Thrombus aspiration has shown beneficial clinical 
outcomes in stent thrombosis management8 and should be 
considered in these cases. In a large registry of patients 
with stent thrombosis around 50% of cases were treated 
with repeat stenting.9 Interestingly, in a more recent study 
that used OCT-guided PCI to evaluate and treat stent 
thrombosis, only 31% of the patients were treated with 
redo stent implantation4, suggesting that adjunctive 
intracoronary imaging may reduce unnecessary repeat 
stenting that might increase risk of restenosis and 
reocclusion.10 In addition, intensive antithrombotic 
pharmacotherapy has been used in the majority of reported 
cases of stent thrombosis4, 9 and in our case appeared 
effective in reducing thrombotic burden. 
Identifying the underlying mechanism of stent 
thrombosis is of major importance as it can guide 
management strategy. In case of a malapposed stent, 
balloon angioplasty could be sufficient treatment, while in 
case of stent edge dissection an additional stent could be 
required. Intravascular imaging can both provide vital 
information regarding different mechanisms of stent 
thrombosis and successfully guide the subsequent 
corrective intervention. OCT provides higher resolution 
compared to intravascular ultrasound and is considered 
superior for detecting responsible mechanisms of 
thrombosis.11 Use of OCT in a cohort of patients with stent 
thrombosis identified the underlying mechanism in 97% of 
the cases.4 In our case, OCT examination identified stent 
undersizing and malapposition as the most probable 
mechanism for the subacute stent thrombosis during the 
revision coronary angiogram. Balloon angioplasty was 
used to correct mechanical abnormalities and a final OCT 
control verified a satisfactory result. Finally, knowledge of 
previous stent sizes and implantation technique is 
necessary to understand limitations and determine realistic 
objectives for the corrective PCI. 
Although management of stent thrombosis is 
challenging, a stepwise approach aiming firstly to stabilize 
the patient and restore flow TIMI III in the culprit artery 
and secondly to identify and treat the underlying 
mechanism of stent thrombosis should be considered. 
 
Conclusion 
In case of stent thrombosis, the objective should be to 
restore TIMI III flow and reverse the thrombogenic milieu, 
while deferral of repeat stenting should be considered, 
especially when there are possible issues regarding 
previous stents. Intravascular imaging guidance during a 
revision procedure offers better understanding of issues 
with previous stents (such as undersizing, underexpansion, 
malapposition) that may contribute to stent thrombosis and 
accordingly plan a corrective PCI. Further data are 
warranted to help establish optimal treatment strategies in 
the occurrence of stent thrombosis.  
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